• Update of the human parvovirus B19 biology

  A. Servant-Delmas and F. Morinet - 16/02/2016

• Infection with human T-lymphotropic virus types-1 and -2 (HTLV-1 and -2): Implications for blood transfusion safety

  E.L. Murphy - 16/02/2016

• Viral metagenomics and blood safety

  V. Sauvage and M. Eloit - 16/02/2016

• Establishment of a proficiency panel for an external quality assessment programme for the detection of bacterial contamination in platelet concentrates using rapid and cultural detection methods

  T. Vollmer, M. Schmidt, K. Hourfar, V. Schottstedt, L. Pichl, K. Gubbe, C. Knabbe and J. Dreier - 05/02/2016

• Optimization of the management of platelet concentrate stocks in the Basque Country using mathematical simulation

  M. Á. Pérez Vaquero, C. Gorria, M. Lezaun, F. J. López, J. Monge, C. Eguizabal and M. A. Vesga - 02/02/2016

• Nouveaux risques viraux en transfusion sanguine à l'horizon 2016

  B. Pozzetto, O. Garraud - 16/01/2016

• Modeling complete removal of risk assessment questions in the USA predicts the risk of HIV exposure in blood recipients could increase despite the use of nucleic acid testing

  H. Yang, S. A. Anderson, R. Forshee, A. Williams, J. S. Epstein and P. W. Marks - 14/01/2016

• Estimating the risk of dengue transmission from Dutch blood donors travelling to Suriname and the Dutch Caribbean

  W. Oei, R. W. Lieshout-Krikke, M. E. Kretzschmar, H. L. Zaaijer, R. A. Coutinho, M. Eersel, B. Jubit - 14/01/2016

• Séroprévalence des virus des hépatites B et C, du VIH-1/2 et de la syphilis chez les donneurs de sang de l'hôpital central de Yaoundé, région du centre, Cameroun

  F. Ankouane, D. Noah Noah, M.M. Atangana, R. Kamgaing Simo, P.R. Guekam, M. Biwolé Sida - 12/01/2016